181025-98-9

Upstream product

• 116-11-0 2-Methoxypropene 
• 181025-97-8 Acetic acid (2R,3S,4S,5R,6R)-5-benzyloxy-3,4-dihydroxy-6-phenylsulfanyl-tetrahydro-pyran-2-ylmethyl ester 
• 173314-29-9 phenyl 2-O-benzyl-1-thio-α-D-glucopyranoside 

Downstream Products

• 1371567-95-1 C₂₅H₂₉BrO₈ 
• 181025-99-0 Acetic acid (3aR,4R,6S,7R,7aS)-7-benzyloxy-6-chloro-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-4-ylmethyl ester 
• 181026-06-2 C₅₉H₈₄O₂₉ 
• 181026-02-8 6-[(2S,3R,4S,5R,6R)-4,5-Diacetoxy-6-acetoxymethyl-3-((3aR,4R,6R,7R,7aS)-4-acetoxymethyl-7-benzyloxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yloxy)-tetrahydro-pyran-2-yloxy]-hexanoic acid methyl ester 

Relevant academic research and scientific papers

Chemical approaches to bacterial vaccines. Synthesis of mycobacterial oligosaccharide-protein conjugates for use as serodiagnostics and immunogens

Di- to penta-saccharide fragments (2-5) of Polysaccharide II (PS-II) of Mycobacterium tuberculosis were synthesized in spacer-linked form in a stepwise fashion using a new glycosyl donor featuring a trans-fused isopropylidene diol-protecting group. Covalent attachment of the oligosaccharides to proteins provides semi-synthetic antigens and immunogens which are being used to probe the role of PS-II as a possible mycobacterial antigen.